Our product is the first screening kit in the market with a selection of evolved fungal unspecific peroxygenases (UPOs), designed to achieve scalable production of chemicals and human drug metabolites.
Coming from different fungal species (short and long-type UPO families), our exclusive collection of evolved UPOs can perform an extensive range of selective oxyfunctionalizations on pharmacological compounds, emulating the role of human liver P450 monoxygenases. Unlike P450s, UPOs simply use H2O2 as an oxidant, making laboratory manipulations easier and more robust.
The catalytic repertoire of the selected UPOs in EVOkit are relevant to both the pharmaceutical and chemical sector, and its portfolio includes alkyl and aromatic hydroxylations, aliphatic and aromatic epoxidations, O-dealkylations, N-dealkylations (including ester and ether cleavage), N-oxidations, S-oxidations and brominations.
Our best mutants
Our fungal peroxygenase kit is presented in glass vials to carry out efficient and directed screening, following a step-by-step protocol. It contains 12 evolved UPO variants selected for their catalytic properties, encompassing a wide array of biotransformations and selectivity.
To make the assay easier, the EVOkit also contains three accessory vials with reaction buffer, hydrogen peroxide and a UPO substrate to use it as a positive control.
We also offer constant support to our customers to assist them with any specific reactions they wish to carry out with the EVOkit.
EVOkit case study
Synthesis of human drug metabolites
We have tested two engineered UPO variants in the EVOkit for their capacity to synthesise authentic human drug metabolites (HDMs). They do this from three pharmaceutical compounds of interest: dextromethorphan, naproxen and tolbutamide.
EvoEnzyme can prepare kits with alternative formats adjusted to specific testing scenarios. In this sense, we can adapt EVOkit to the screening of multiple chemical entities. Also the Company is developing non-standard versions of the kit with immobilized enymes.
EvoEnzyme has considerable experience in adapted biocatalysis, especially in setting-up peroxygenase reactions. Our clients may also be interested in undertaking an exploratory assay to test the EVOkit for a specific biotransformation or challenge at our company’s facilities. After careful analysis, a detailed report will be provided that details the best candidate enzymes and our team of experts will also advise you as to how you can optimize your process to achieve your objectives.
The main expertise of EvoEnzyme is to identify the best customized biocatalyst for the costumer’s process. Once the EVOkit has been tested and the best candidates chosen, the company offers the possibility of further development through ad-hoc directed evolution campaigns that aim to meet the long-term goals of our customers. These projects may include the design of specific high-throughput screening assays and library creation methods (based on the company’s EvoShuffler yeast technology), as well as mutant analysis and scale-up production.
The EVOkit tool-box of evolved peroxygenases can be particularly useful in the drug discovery pipeline for late-stage functionalization processes. Based on our experience in UPO mediated transformations, new molecules can be obtained by biocatalysis through the introduction of functional groups and the screening of the chemical libraries constructed.